ACUPUNCTURE IMPROVES THE EFFECTS OF CHINESE HERBAL MEDICINE IN TREATING ENDOMETRIOSIS MODEL RATS by J Shi et al.
Shi et al J. Anim. Plant Sci. 23(1):2013
298
ACUPUNCTURE IMPROVES THE EFFECTS OF CHINESE HERBAL MEDICINE IN
TREATING ENDOMETRIOSIS MODEL RATS
J. Shi, Z. B. Z. Ge*, Y. Jin,Y. D. Li and J. Zhou**
The 1st Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, China
*Sir Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, Zhejiang, China
**College of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, Zhejiang, 310012, China.
Corresponding Author Email: juezhou2006@yahoo.com.cn
ABSTRACT
The present study was aimed to investigate whether acupuncture could significantly enhance the efficacy of Chinese
herbal medicine (CHM) in treating endometriosis model rats. A total of 40 female Sprague-Dawley (SD) rats with body
weight of 200 ±20 g were included. Operational transplantation was used with animal models. The rats were randomly
divided into 5 groups: sham-operation control group (Group A), model group (Group B), CHM combined with
acupuncture group (Group C), CHM group (Group D), Danazol group (Group E) with 8 rats in each group. During the
treatment, two rats in Group B and one rat in Group E passed away. When the treatment ended, all the left rats were
sacrificed. The samples of peritoneal fluids, serum and the ectopic endometrium were taken. The serum levels of cancer
antigen 125 (CA-125) and interleukin 18(IL-18) in the peritoneal fluids were detected using enzyme-linked
immune-sorbent assay. The cyclooxygenase-2 (COX-2) mRNA expression levels in the ectopic endometrium were
measured by Real-time PCR. The results showed that in the rats from Groups A, C, D and E, the serum CA-125 levels,
COX-2 mRNA expression in the ectopic endometrium and the IL-18 levels in the peritoneal fluids were significantly
lower than those of Group B (P<0.05). The serum CA-125 levels and COX-2 mRNA expression in the ectopic
endometrium of the rats in Group C were significantly lower than those of Group D (P<0.05), while there was no
significant difference between Group C and E (P>0.05). The levels of IL-18 in the peritoneal fluids of the rats in Group
C were markedly lower than those of Group D and E (P<0.05). It is then concluded that acupuncture treatment can
improve the effects of CHM in treating endometriosis model rats.
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INTRODUCTION
Endometriosis in humans is characterized by the
presence of endometrial tissue outside the uterus (Giudice
and Kao, 2004). It can cause both pain symptoms
(dysmenorrhoea, deep dyspareunia, and chronic pelvic
pain) as well as infertility (Ferrero et al., 2010). The
disease affects from 10% of all reproductive-aged women
to as many as 70% of the women suffering from
infertility or chronic pelvic pain worldwide (Ferrero et al.,
2010; Guo and Wang, 2006a; Guo and Wang, 2006b;
Simoens et al., 2007; Sinaii et al., 2007; Vigano et al.,
2004). However, the pathogenesis of endometriosis
remains incomplete (Sharpe-Timms and Young, 2004).
Although medical treatments for endometriosis have
benefits (Brown et al., 2010; Davis et al., 2007; Prentice
et al., 2000; Selak et al., 2001), they are often
characterized by the possibility of unpleasant short- and
long-term side-effects (Sagsveen et al., 2003). The
treatments may usually lead to high rates of relapse once
medication is stopped and the treatment of endometriosis
is far from satisfactory (Flower et al., 2011).
Chinese herbal medicine (CHM) and
acupuncture have advantages in treating endometriosis
(Chen et al., 2010; Flower et al., 2009; Lundeberg and
Lund, 2008; Meissner et al., 2010; Schnyer et al., 2008;
Wang, 1994; Xiang et al., 2011; Zhu et al., 2011). CHM
is useful in relieving endometriosis-related pain with
fewer side effects than experienced with conventional
treatment (Flower et al., 2009). A commonly used
anti-endometriosis herb preparation (Channel Flow)
consisting of nine individual Chinese medical herbs was
found to have direct effects on cell proliferation,
apoptosis, and CCL5 production in endometriotic stromal
cells (Wieser et al., 2009). The findings support the
potential of novel, potentially safe and well-tolerated
botanical products as the future endometriosis treatments
(Wieser et al., 2009). Although a recent systematic
review recommended well-designed, double-blinded,
randomized controlled trials that assess various types of
acupuncture in comparison to conventional therapies
need to be conducted, the limited effectiveness of
acupuncture for pain in endometriosis is demonstrated
(Zhu et al., 2011).
However, few studies have been focused on the
effects of CHM combined with acupuncture on the
endometriosis model rats. The study was aimed to
investigate whether acupuncture could significantly
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enhance the efficacy of CHM in treating endometriosis
model rats. The serum levels of cancer antigen 125
(CA-125), interleukin 18(IL-18) in the peritoneal fluids
and cyclooxygenase-2 (COX-2) mRNA expression levels
in the ectopic endometrium were detected in this study.
MATERIALS AND METHODS
Preparation of the Extracts of the Chinese Formula:
The composition of CHM formula used to treat
endometriosis was shown as Table 1. The crude drugs of
this formula were extracted by 10x boiling water for
60min. After filtrate, the extraction procedure was
repeated once with 8x boiling water. All the filtrates were
combined and condensed under reduced pressure and
freeze dried.
Animals, groups and administration: A total of 40
female Sprague-Dawley (SD) rats with body weight of
200 ±20 g were purchased from the Laboratory Animal
Center of Zhejiang University (Hangzhou, China). The
whole protocol of the study was conducted based on the
National Research Council's protocol for the care and use
of laboratory animals and was approved by the
Institutional Review Board. Among the 40 rats, 8 rats
were randomly taken as the sham-operation control group
(Group A). For the rats in Group A, after the abdominal
fur was shaved and the skin disinfected, the abdominal
cavity was opened and then closed, which was used to
insure aseptic conditions (references). The other 32 rats
were used to establish the model rats with endometriosis.
Operational transplantation was used with animal models.
Each rat was injected with 0.2mg Diethylstilbestrol to
stimulate estrus. Then 20% Urethane (1.5g/kg) was
intra-abdominally injected. The animal models were
made: 1)the abdominal fur was shaved and the skin
disinfected, 2)the abdominal cavity was opened, 3)
procedures were done to separate the uterus away from
the right ovary by 0.5cm, and 2cm long section of the
uterus removed. 4) the endometrium was separated and
divided into three parts, which were respectively sutured
in the respective uterine branch, left ovary and parietal
peritoneum. 6) the abdominal cavity was closed.
Gentamycin Sulfate (0.1ml) was injected into each rat for
3 days after finishing the above operation. Danazol was
provided by Lianhua Medicine Company (Jiangsu,
China).
Four weeks after the 32 model rats were
established, after confirming the ectopic endometrium
were survived with histopathology examination, the
model rats were randomly divided into 4 groups. In
addition to Group A, all the rats were then divided into 5
groups as shown in Table 2. In the acupuncture treatment,
Guanyuan (RN4), Sanyinjiao (SP 6), Zusanli (ST 36),
Shensu (BL23) and Dazhui (Du14) were selected as the
acupoints. All the acupoints and the stainless steel
needles were sterilized with 75% alcohol. The rats were
anesthetized with sodium pentobarbital (40 mg/kg, i.p.)
before acupuncture treatment. After the needles were
inserted into the acupoints, they were connected to an
electro-therapeutic apparatus (Model G6805-2, Shanghai,
China) for 25 min through clip electrodes.
Detection index and method: During the treatment, two
rats in Group B and one rat in Group E passed away.
When the treatment ended, the remaining rats were
sacrificed. The samples of peritoneal fluids, serum and
the ectopic endometrium were taken. The peritoneal fluid
samples of the rats were centrifuged at 12,000 rpm for 10
min at 4 ℃. Then, the supernatants were collected,
aliquoted, and stored frozen at ℃−80  until used for
further evaluation. The serum levels of CA-125 and the
levels of IL-18 in the peritoneal fluids were detected
using enzyme-linked immune-sorbent assay (ELISA,
RUIQI Bio Co. Ltd, Shanghai, China). All the
measurements were carried out in duplicate and were
conducted according to the manufacturer’s instruction.
Both intra- and inter-assay coefficients of variation were
less than 10%. The COX-2 mRNA expression levels in
the ectopic endometrium were measured by Real-time
PCR.
Detection of COX-2 mRNA expression by Real-time
PCR: Isolation of the total RNA was performed by using
the RNAisoTM Reagent (TAKARA, Dalian, China),
according to the manufacturer’s instructions. The purity
and concentration of RNA were determined by
NanoDrop®ND-100 Spectrophotometer (Thermo Fisher
Scientific Inc, USA).The cDNA was prepared from
500ng of total RNA by reverse transcription, using the
PrimeScriptTM RT reagent Kit (Perfect Real Time,
TAKARA, Dalian, China). The cDNA samples were
diluted in DNase- and RNase-free water at a proportion
of 1:3 before further analysis. Quantitative real-time PCR
was performed by using the iCycler iQ Real-Time
Detection System (Bio-Rad). The PPARG and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
gene specific primers for rats were provided by Sangon,
Shanghai, China. PCR reactions were carried out using
2μL of cDNA, 1 μL of 10 μM of each primer, 8.5 μL of
dH2O and 12.5μL of 2×SYBR® Premix Ex TaqTM
(TAKARA) in 25-μL reactions. Thermal cycling
conditions were 95°C for 30 seconds, followed by 40
cycles of 95°C for 5 seconds and 60.0°C for 30 seconds.
A final melting curve verified formation of
single-product. Gene starting quantity was based on the
cycle threshold (Ct) method. A control cDNA dilution
series of known concentration was constructed for each
gene to establish a standard curve, plotting the logarithm
of the standard concentration against the Ct values. The
samples were quantified from the measured Ct values by
interpolation, using the regression equation.
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Statistical analysis: Data were analyzed using the
Statistical Package for Social Sciences (SPSS 15.0 for
Windows). The comparisons among different groups
were performed with one-way analysis of variance
(ANOVA) and multiple comparison tests were conducted
with Bonferroni correction procedure. For all the
hypothesis tests, significance level was set at P=0.05 and
two-tailed tests were used.
RESULTS
Serum CA-125 levels: The results for the serum CA-125
are shown in Figure 1.The rats from Groups A, C, D and
E had significantly lower CA-125 levels than those of
Group B (P<0.05). The serum CA-125 levels of the rats
in Group C were significantly lower than that of Group D
(P<0.05), while there was no significant difference
between Group C and E (P>0.05).
Table 1. The composition of CHM formula
Chinese medicinal herb Dosage (g)
Concha Ostreae 25
Radix Scutellariae 20
Radix Paeoniae Rubra 20
Rhizoma Curcumae 15
Radix Bupleuri 15
Rhizoma Atractylodis Macrocephalae 10
Radix Salviae Miltiorrhizae 10
Semen Coicis 10
Spica Prunellae 10









8 8 The rats were orally administrated saline at 8ml/kg once daily for 56
consecutive days.
Model group (Group B) 8 6 The rats were orally administrated saline at 8ml/kg once daily for 56
consecutive days.
CHM combined with acupuncture
group (Group C)
8 8 The rats were orally administrated the extracts of CHM at 380 mg/kg once
daily and acupuncture treatment was taken every two days for 56
consecutive days.
CHM group (Group D) 8 8 The rats were orally administrated the extracts of CHM at 380 mg/kg once
daily for 56 consecutive days.
Danazol group (Group E) 8 7 The rats were orally administrated danazol at 36 mg/kg once daily for 56
consecutive days.
Figure 1. The serum CA-125 levels. Data were shown as mean ±
SD. (n=8 in Group A, C and D; n=6 in Group B; n=7
in Group E). The significant difference was set at *
P<0.05, compared with Group B; # P<0.05, Group D
and E compared with Group C.
COX-2 mRNA expression in the ectopic endometrium:
The results for the COX-2 mRNA expression in the
ectopic endometrium are shown in Figure 2. The rats
from Groups A, C, D and E had significantly lower
COX-2 mRNA expression in the ectopic endometrium
than those of Group B (P<0.05). COX-2 mRNA
expression in the ectopic endometrium of the rats in
Group C were significantly lower than that of Group D
(P<0.05), while no significant difference existed between
Group C and E (P>0.05).
IL-18 levels in the peritoneal fluids: The results for the
IL-18 levels in the peritoneal fluids are shown in Figure 3.
The rats from Groups A, C, D and E had significantly lower
IL-18 levels in the peritoneal fluids than those of Group B
(P<0.05). The Compared with Group D and E, the levels of
IL-18 in the peritoneal fluids of the rats in Group C were
markedly lower (P<0.05). The levels of IL-18 in the
peritoneal fluids of the rats in Group E were markedly lower
than that of Group D (P<0.05).
Figure 2. The COX-2 mRNA expression in the ectopic
endometrium. Data were shown as mean ± SD. (n=8 in
Group A, C and D; n=6 in Group B; n=7 in Group E).
The significant difference was set at * P<0.05, compared
with Group B; # P<0.05, Group D and E compared with
Group C.
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Figure 3. The IL-18 levels in the peritoneal fluids. Data were
shown as mean ± SD. (n=8 in Group A, C and D;
n=6 in Group B; n=7 in Group E). The significant
difference was set at * P<0.05, compared with
Group B; # P<0.05, Group D and E compared with
Group C.
DISCUSSION
Endometriosis is a common, benign,
oestrogendependent, chronic gynaecological disorder
associated with pelvic pain and infertility (Giudice and
Kao, 2004; Guillebaud, 1993; Parazzini and Ferraroni,
1993; Prentice, 1993; Vessey et al., 1993). However, the
aetiology and pathogenesis remain uncertain (Giudice
and Kao, 2004), which may lead to no satisfactory
treatment for endometriosis. In the present study, we
successfully established the endometriosis model rats and
we found acupuncture treatment can improve the effects
of CHM in treating endometriosis model rats.
CA-125 is the most widely used marker for
endometriosis (Barbieri, 1987; Ozaksit et al., 1995;
Patton et al., 1986; Pittaway et al., 1995; Ramos et al.,
2012). Some studies have assessed the value of CA-125
measurements during treatment (Chen et al., 1998;
Matalliotakis et al., 2004). IL-18 levels in the peritoneal
fluid was found to elevate in women with
endometriosis(Arici et al., 2003; Zhang et al., 2005).
IL-18-607 A homozygote and A allele were found to be
positively correlated with the risk of developing
endometriosis or the stage of endometriosis(Ayaz et al.,
2011). COX-2 expression increased in the eutopic
endometrium and ovarian endometriotic tissue of the
patients with endometriosis, indicating that COX-2 may
be involved in the pathogenesis and progression of
endometriosis(Cho et al., 2010). The increased COX-2
expression in eutopic and ectopic endometria was
believed to be strongly correlated with pathological
abnormalities in endometriosis (Ota et al., 2001). Hyper
activation of COX-2 with abnormal prostaglandin
generation is considered to contribute to the
patho-physiology of endometriosis and the progression
(Chishima et al., 2002). The elevated COX-2 expression
in stromal cells in eutopic endometrium from patients
with deep endometriosis may play a role in severe,
endometriosis-related dysmenorrheal (Matsuzaki et al.,
2004) and COX-2 selective inhibitors could be effective
to suppress the establishment and growth of
endometriosis, partially through their antiangiogenic
activity(Machado et al., 2010). Although we have
demonstrated the effects of acupuncture in improving
CHM in treating endometriosis rats, a more systematic
study is needed and more studies designated to explore
the underlying mechanism underlying acupuncture
improving the effects of CHM in treating endometriosis
should be done in the future.
Acknowledgements: The present research was funded by
Zhejiang Administration of Traditional Chinese Medicine
(No. 2011ZA048 and partly by 2008YA023); Health
Department of Zhejiang Province (No. 2011KYA053)
and Zhejiang Provincial Education Department (No.
Y201016894). Dr Jue Zhou is funded by Science and
Technology foundation of Overseas Scientists of
Zhejiang Province (No. 2011443); Young Scientist Grant
of Zhejiang Gongshang University (No. QY11-20).
REFERENCES
Arici, A., I. Matalliotakis, A. Goumenou, G. Koumantakis,
S. Vassiliadis and N. G. Mahutte (2003). Altered
expression of interleukin-18 in the peritoneal
fluid of women with endometriosis. Fertil Steril.
80 (4):889-894.
Ayaz, L., S. K. Celik, F. Cayan, N. Aras-Ates and L.
Tamer (2011). Functional association of
interleukin-18 gene -607 C/A promoter
polymorphisms with endometriosis. Fertil Steril.
95 (1):298-300.
Barbieri, R. L. (1987). CA-125 and endometriosis.
Contrib Gynecol Obstet. 16 103-108.
Brown, J., Pan, A. and R. J. Hart (2010).
Gonadotrophin-releasing hormone analogues for
pain associated with endometriosis. Cochrane
Database Syst Rev. (12):CD008475.
Chen, F. P., Y. K. Soong, N. Lee and S. K. Lo (1998). The
use of serum CA-125 as a marker for
endometriosis in patients with dysmenorrhea for
monitoring therapy and for recurrence of
endometriosis. Acta Obstet Gynecol Scand. 77
(6):665-670.
Chen, M., H. Zhang, J. Li, , and G. R. Dong (2010).
[Clinical observation on acupuncture combined
with acupoint sticking therapy for treatment of
dysmenorrhea caused by endometriosis].
Zhongguo Zhen Jiu. 30 (9):725-728.
Chishima, F., S. Hayakawa, K. Sugita, N. Kinukawa, S.
Aleemuzzaman, N. Nemoto, T. Yamamoto and
M. Honda (2002). Increased expression of
cyclooxygenase-2 in local lesions of
endometriosis patients. Am J Reprod Immunol.
Shi et al J. Anim. Plant Sci. 23(1):2013
302
48 (1):50-56.
Cho, S., S. H. Park, Y. S. Choi, S. K. Seo, H. Y. Kim, K.
H. Park, D. J. Cho and B. S. Lee (2010).
Expression of cyclooxygenase-2 in eutopic
endometrium and ovarian endometriotic tissue
in women with severe endometriosis. Gynecol
Obstet Invest. 69 (2):93-100.
Davis, L., S. S. Kennedy, J. Moore and A. Prentice (2007).
Modern combined oral contraceptives for pain
associated with endometriosis. Cochrane
Database Syst Rev. (3):CD001019.
Ferrero, S., V. Remorgida and P. L. Venturini (2010).
Current pharmacotherapy for endometriosis.
Expert Opin Pharmacother. 11 (7):1123-1134.
Flower, A., G. T. Lewith and P. Little (2011). A feasibility
study exploring the role of Chinese herbal
medicine in the treatment of endometriosis. J
Altern Complement Med. 17 (8):691-699.
Flower, A., J. P. Liu, S. Chen, G. Lewith and P. Little
(2009). Chinese herbal medicine for
endometriosis. Cochrane Database Syst Rev.
(3):CD006568.
Giudice, L. C. and L. C. Kao (2004). Endometriosis.
Lancet. 364 (9447):1789-1799.
Guillebaud, J. (1993). Epidemiology of endometriosis.
BMJ. 306 (6882):931.
Guo, S. W. and Y. Wang, (2006a). The prevalence of
endometriosis in women with chronic pelvic
pain. Gynecol Obstet Invest. 62 (3):121-130.
Guo, S. W., and Y. Wang (2006b). Sources of
heterogeneities in estimating the prevalence of
endometriosis in infertile and previously fertile
women. Fertil Steril. 86 (6):1584-1595.
Lundeberg, T. and I. Lund (2008). Is there a role for
acupuncture in endometriosis pain, or
'endometrialgia'? Acupunct Med. 26 (2):94-110.
Machado, D. E., P. T. Berardo, R. G. Landgraf, P. D.
Fernandes, C. Palmero, L. M. Alves, M. S.
Abrao and L. E. Nasciutti (2010). A selective
cyclooxygenase-2 inhibitor suppresses the
growth of endometriosis with an antiangiogenic
effect in a rat model. Fertil Steril. 93
(8):2674-2679.
Matalliotakis, I. M., A. Arici, A. G. Goumenou, T.
Katassos, N. Karkavitsas and E. E. Koumantakis
(2004). Comparison of the effects of leuprorelin
acetate and danazol treatments on serum
CA-125 levels in women with endometriosis. Int
J Fertil Womens Med. 49 (2):75-78.
Matsuzaki, S., M. Canis, J. L. Pouly, A. Wattiez, K.
Okamura and G. Mage (2004).
Cyclooxygenase-2 expression in deep
endometriosis and matched eutopic
endometrium. Fertil Steril. 82 (5):1309-1315.
Meissner, K., B. Bohling and A. Schweizer-Arau (2010).
Long-term effects of traditional Chinese
medicine and hypnotherapy in patients with
severe endometriosis--a retrospective evaluation.
Forsch Komplementmed. 17 (6):314-320.
Ota, H., S. Igarashi, M. Sasaki and T. Tanaka (2001).
Distribution of cyclooxygenase-2 in eutopic and
ectopic endometrium in endometriosis and
adenomyosis. Hum Reprod. 16 (3):561-566.
Ozaksit, G., T. Caglar, N. Cicek, E. Kuscu, S. Batioglu
and O. Gokmen (1995). Serum CA 125 levels
before, during and after treatment for
endometriosis. Int J Gynaecol Obstet. 50
(3):269-273.
Parazzini, F. and M. Ferraroni (1993). Epidemiology of
endometriosis. BMJ. 306 (6882):930-931.
Patton, P. E., C. S. Field, R. W. Harms and C. B. Coulam
(1986). CA-125 levels in endometriosis. Fertil
Steril. 45 (6):770-773.
Pittaway, D. E., D. Rondinone, K. A. Miller and K.
Barnes (1995). Clinical evaluation of CA-125
concentrations as a prognostic factor for
pregnancy in infertile women with surgically
treated endometriosis. Fertil Steril. 64
(2):321-324.
Prentice, A. (1993). Epidemiology of endometriosis. BMJ.
306 (6877):585.
Prentice, A., A. J. Deary and E. Bland (2000).
Progestagens and anti-progestagens for pain
associated with endometriosis. Cochrane
Database Syst Rev. (2):CD002122.
Ramos, I. M., S. Podgaec, M. S. Abrao, R. Oliveira and E.
C. Baracat (2012). Evaluation of CA-125 and
soluble CD-23 in patients with pelvic
endometriosis: a case-control study. Rev Assoc
Med Bras. 58 (1):26-32.
Sagsveen, M., J. E. Farmer, A. Prentice and A. Breeze
(2003). Gonadotrophin-releasing hormone
analogues for endometriosis: bone mineral
density. Cochrane Database Syst Rev.
(4):CD001297.
Schnyer, R. N., D. Iuliano, J. Kay, M. Shields and P.
Wayne (2008). Development of protocols for
randomized sham-controlled trials of complex
treatment interventions: Japanese acupuncture
for endometriosis-related pelvic pain. J Altern
Complement Med. 14 (5):515-522.
Selak, V., C. Farquhar, A. Prentice and A. Singla (2001).
Danazol for pelvic pain associated with
endometriosis. Cochrane Database Syst Rev.
(4):CD000068.
Sharpe-Timms, K. L. and S. L. Young (2004).
Understanding endometriosis is the key to
successful therapeutic management. Fertil Steril.
81 (5):1201-1203.
Simoens, S., L. Hummelshoj and T. D'Hooghe (2007).
Endometriosis: cost estimates and
Shi et al J. Anim. Plant Sci. 23(1):2013
303
methodological perspective. Hum Reprod
Update. 13 (4):395-404.
Sinaii, N., S. D. Cleary, S. D. Younes, M. L. Ballweg and
P. Stratton (2007). Treatment utilization for
endometriosis symptoms: a cross-sectional
survey study of lifetime experience. Fertil Steril.
87 (6):1277-1286.
Vessey, M. P., L. Villard-Mackintosh and R. Painter
(1993). Epidemiology of endometriosis in
women attending family planning clinics. BMJ.
306 (6871):182-184.
Vigano, P., F. Parazzini, E. Somigliana and E. Vercellini
(2004). Endometriosis: epidemiology and
aetiological factors. Best Pract Res Clin Obstet
Gynaecol. 18 (2):177-200.
Wang, D. Z. (1994). Diagnosis and treatment of
endometriosis with traditional Chinese medicine.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 14
(2):112-114.
Wieser, F., E. Yu, E. Park, E. Gaeddert, E. Cohen, J. L.
Vigne and R. N. Taylor (2009). A botanical
extract from channel flow inhibits cell
proliferation, induces apoptosis, and suppresses
CCL5 in human endometriotic stromal cells.
Biol Reprod. 81 (2):371-377.
Xiang, D. F., Q. Z. Sun and X. F. Liang (2011). Effect of
abdominal acupuncture on pain of pelvic cavity
in patients with endometriosis. Zhongguo Zhen
Jiu. 31 (2):113-116.
Zhang, Y., L. X. Peng and L. Meng (2005).
Measurements of interleukin-18 in peritoneal
fluid and serum of patients with endometriosis.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 30
(6):731-732.
Zhu, X., K. D. Hamilton and E. D. McNicol (2011).
Acupuncture for pain in endometriosis.
Cochrane Database Syst Rev. 9 CD007864.
